Financial Results Briefing

for Q2 FY2023

May 12, 2023

This report contains forward-looking statements on business performance based on the judgments, assumptions, and beliefs of management using the information available at the time. Actual results may differ materially due to changes in domestic or overseas economic conditions or changes in internal or external business environments or aspects of uncertainty contained in the forecasts, latent risks or various other factors. In addition, risk and uncertainty factors include unpredictable elements that could arise from future events.

Contents

P.01 Financial Results

P.20 Approach in Q3 and beyond

Overview for Q2 FY2023

02

Financial highlight

21 Basic policies and priority issues

03

Consolidated P/L

for FY2023

04

Consolidated SG&A

22 Cloud drug record service

06

Difference between earning

24 Maternal and child health handbook app

forecast and the actual for Q2

+ Childcare DX services

07

Revision of earnings forecast of FY2023

31

School DX business

08

Performance by segment

34

Image of medium-term profit

P.36 Appendix

37

Earning forecast of FY2023

42

The list of main healthcare services

38

Consolidated B/S

43

Overview of healthcare services

39

Trends in consolidated P/L

44

Cloud drug record service

40

Trends in consolidated SG&A

47

Maternal and child health handbook

41

Performance by segment

48

School DX business

Copyrights (c) 2023 MTI Ltd. All Right Reserved

Financial Results Overview

for Q2 FY2023

Copyrights (c) 2023 MTI Ltd. All Right Reserved

1

Financial highlight

  • Operating income declined and was below the forecast.
    Main cause: Loss-making projects in DX support business for major companies.

Net sales: ¥13,613 million (+¥638 million, YoY, Performance forecast comparison: +¥913 million)

Operating income: ¥(18) million (-¥617 million, YoY, Performance forecast comparison: -¥218 million)

Ordinary income: ¥187 million (-¥105 million, YoY, Performance forecast comparison: +¥187 million)

2 The full-year forecasts are revised.

(only operating income is revised downward)

Net sales: ¥26,800 million (Compared to the previous forecast +¥800)

Operating income: ¥200 million

(Compared to the previous forecast -¥600)

Ordinary income: ¥400 million

(Previous forecast unchanged)

3 Healthcare business and School DX business: Results improved as planned.

Other business: Loss-making projects in the DX support business for major

companies continued being dealt with the aim of winding them down in the course of this fiscal year.

Copyrights (c) 2023 MTI Ltd. All Right Reserved

2

Consolidated P/L

Net sales : increased

Operating income : decreased

UnitMil yen

FY2022

Q2

Net sales

12,975

Cost of sales

3,814

ratio)

29.4%

Gross profit

9,160

ratio

70.6%

SG&A

8,561

ratio

66.0%

Operating income

599

ratio

4.6%

Ordinary income

292

ratio

2.3%

Profit attributable to

123

owners of parent

ratio

1.0%

YoY

Amount Percentage

+638 +4.9%

+666

+17.5%

  1. (0.3)%

+589

+6.9%

  1. -%
  1. (36.1)%
  1. -%

Q1: Posting of spot sales of the video- streaming service

Posting of spot cost of sales of the video- streaming service

Increase in outsourcing expenses. (School DX business) Increase in advertising expenses (AdGuard)

Q1: Posting of income taxes associated with the transfer of shares between Group companies

Copyrights (c) 2023 MTI Ltd. All Right Reserved

3

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

MTI Ltd. published this content on 19 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 May 2023 09:39:08 UTC.